SM_206a: CKD Clinical Flashcards

(36 cards)

1
Q

Stage 1 CKD is GFR ____

A

Stage 1 CKD is GFR ≥ 90

(kidney damage with normal or increased GFR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Stage 2 CKD is GFR ____

A

Stage 2 CKD is GFR 60-89

(kidney damage with mildly decreased GFR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Stage 3 CKD is GFR ____

A

Stage 3 CKD is GFR 30-59

(moderately decreased GFR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Stage 4 CKD is GFR ____

A

Stage 4 CKD is GFR 15-29

(severely decreased GFR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Stage 5 CKD is GFR ____

A

Stage 5 CKD is GFR < 15 (or ESRD)

(kidney failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CKD is defined as _____ and classified based on _____

A

CKD is defined as abnormalities of kidney structure or function present for > 3 months with implications on health and is classified based on cause, GFR category, and albuminuria category

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Serum creatinine is not entirely accurate for measuring GFR because of _____, _____, and _____

A

Serum creatinine is not entirely accurate for measuring GFR because of variable creatinine production, variable creatinine secretion, and extra-renal secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Relationship between GFR and creatinine is _____

A

Relationship between GFR and creatinine is non-linear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the systemic consequences of CKD

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the reciprocal relationship between drugs and kidney function

A

Reciprocal relationship between drugs and kidney function

  • Renal excretory capacity leads to drug accumulation
  • Drug accumulation can accelerate kidney disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Greater sodium intake is associated with ____ proteinuria in CKD

A

Greater sodium intake is associated with greater proteinuria (induces hyperinflation)

(interaction with profibrotic effects of aldosterone, activate local RAAS in vessels and enhance conversion of Angiotensin I to Angiotensin II)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment with an ARB + thiazide _____ proteinuria in CKD

A

Treatment with an ARB + thiazide lowers proteinuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Giving bicarbonate _____ creatinine clearance in CKD

A

Giving bicarbonate raises creatinine clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CKD can lead to _____ due to disorder iron balance

A

CKD can lead to iron deficiency anemia due to disorder iron balance

(chronic inflammation and reduced renal clearance in CKD -> increased hepcidin -> reduced duodenal iron uptake and enhanced iron release from cellular iron stores)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Roxadustat is an _____ that is used to treat _____ in CKD patients

A

Roxadustat is an HIP inhibitor that is used to treat iron deficiency anemia in CKD patients

(blocks hepcidin -> allows formation of RBCs -> stops anemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CKD leads to a _______ disorder due to abnormal Ca2+, P3-, PTH, and Vitamin D metabolism

A

CKD leads to a mineral bone disorder due to abnormal Ca, P, PTH, and Vitamin D metabolism

17
Q

_____ fluctuates by the second to keep Ca2+ in a narrow range

A

PTH fluctuates by the second to keep Ca2+​ in a narrow range

18
Q

Hypoparathyroidism is ___ PTH and ___ Ca2+

A

Hypoparathyroidism is low PTH and low Ca2+

(hyperphosphatemia)

19
Q

Hyperparathyroidism is ___ PTH and ___ Ca2+

A

Hyperparathyroidism is high PTH and high Ca2+

(hypophosphatemia)

20
Q

_____ is associated with low PTH and high Ca2+

A

Malignancy is associated with low PTH and high Ca2+

21
Q

Increased PTH leads to _____ calcitriol, which leads to _____ reabsorption of Ca2+ and P3-

A

Increased PTH leads to increased calcitriol, which leads to increased reabsorption of Ca2+ and P3-

22
Q

____ inhibits calcitriol

A

Calcitriol inhibits calcitriol (is its own inhibitor)

23
Q

FGF23 secreted by osteocytes _____, _____, and _____

A

FGF23 secreted by osteocytes stimulates phosphaturia, decreases 1,25-D levels, and inhibits PTH

24
Q

The trade-off (Bricker) hypothesis states that PTH ____ so Ca2+ can fall as GFR decreases

A

The trade-off (Bricker) hypothesis states that PTH decreases so Ca2+​ can fall as GFR decreases

25
\_\_\_\_ is the first molecule to increase in CKD
FGF23 is the first molecule to increase in CKD (inflammation, iron deficiency)
26
Glomerular _____ occurs in diabetes mellitus
Glomerular hyperinflation occurs in diabetes mellitus (glucose load causes tubule to work harder and hypertrophy)
27
ACE-inhibitors and ARBs _____ glomerular hyperfiltration in CKD
ACE-inhibitors and ARBs decrease glomerular hyperinflation in CKD
28
28
Diabetes mellitus leads to glomerular \_\_\_\_\_
Diabetes mellitus leads to glomerular hypertension (less Na+ delivery to macula densa -\> less ATP converted to adenosine -\> glomerular afferent vasodilation -\> GFR increases)
29
SGLT2 inhibitors _____ intra-glomerular pressure
SGLT2 inhibitors decreases intra-glomerular pressure (block hyperinflation)
30
SGLT2 inhibition leads to afferent \_\_\_\_\_, while RAAS blockade leads to efferent \_\_\_\_\_
SGLT2 inhibition leads to afferent vasoconstriction, while RAAS blockade leads to efferent vasodilation
31
SGLT2 slows progression of ____ and protects against \_\_\_\_\_
SGLT2 slows progression of CKD and protects against cardiovascular disease
32
Describe the clinical action plan for management of CKD
* Early stages: slow progression, reduce CVD risk * Middle stage: reduce CVD risk, treat complications * End stage: work up for transplant (CKD progression defined based on drop in GFR category and/or decline of ≥ 25% in eGFR from baseline - rapid progression is sustained decline of eGFR of \> 5 mL/min/1.73 m2/yr)
33
Once damaged, CKD progresses over time due to \_\_\_\_\_\_\_
Once damaged, CKD progresses over time due to increased work of the remaining nephron mass
34
Describe indications for dialysis
Indications for dialysis * Acute: acidosis, electrolytes (hyperkalemia), ingestions (lithium, ASA), overload (volume overload causing hypoxia, decompensated HF), uremia, nutrition (pediatric) * Chronic: acute indication in setting of CKD (GFR \< 15 cc/min), general malaise or failure to thrive in patient with GFR \< 10-15 cc/min
35
Azotemia is \_\_\_\_\_, while uremia is \_\_\_\_\_
Azotemia is high BUN level, while uremia is high BUN level with symptoms (confusion, encephalopathy, bleeding, asterixis)